Supplementary guidance document for the notification and testing of new substances : organisms used in cell and gene therapy under schedule 1 of the New Substances Notification Regulations (organisms).: En84-240/2021E-PDF
"This supplementary guidance document is intended to complement the Guidelines for the Notification and Testing of New Substances: Organisms (the Guidelines) and provides specific guidance to notifiers on addressing information requirements under Schedule 1 (for release anywhere in Canada, which includes clinical trials) of the New Substances Notification Regulations (Organisms) [the Regulations] for substances that are animate products of biotechnology used in cell and gene therapy and administered to human patients"--page [2].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.898933&sl=0
| Department/Agency |
|
|---|---|
| Title | Supplementary guidance document for the notification and testing of new substances : organisms used in cell and gene therapy under schedule 1 of the New Substances Notification Regulations (organisms). |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 1 online resource (62 unnumbered pages) |
| ISBN | 9780660385297 |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: